Are there any FDA approved insomnia medications that do not cause severe morning grogginess because I have an important presentation at work tomorrow morning?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Are there any FDA approved insomnia medications that do not cause severe morning grogginess because I have an important presentation at work tomorrow morning?
2 real searches · 1 real-search pass
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (2)
Classes come from the query-classifier (a local Laya model). 2 of 2 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT2 real searches · gpt-6
FDA approved insomnia medications next day impairment ramelteon low dose doxepin zaleplon prescribing information 2026 Google ↗
FDA insomnia medication labels next morning impairment lemborexant daridorexant suvorexant ramelteon doxepin Google ↗
- These highlights do not include all the information needed to use RAMELTEON TABLETS safely and effectively. See full prescribing information for RAMELTEON TABLETS. RAMELTEON tablets, for oral use Initial U.S. Approval: 2005 · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use QUVIVIQ safely and effectively. See full prescribing information for QUVIVIQ. QUVIVIQ (daridorexant) tablets, for oral use, CIV Initial U.S. Approval: 2022 · dailymed-us-east-1.awsprod.nlm.nih.gov
- These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019 · dailymed-beta.nlm.nih.gov
- Management of Insomnia Disorder in Adults: Current State of the Evidence · effectivehealthcare.ahrq.gov
- These highlights do not include all the information needed to use ROZEREM® safely and effectively. See full prescribing information for ROZEREM. ROZEREM (ramelteon) tablets, for oral use Initial U.S. Approval: 2005 · dailymed.nlm.nih.gov
- Taking Z-drugs for Insomnia? Know the Risks · fda.gov
- Questions and Answers: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist) · fda.gov
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA approved insomnia medications next day impairment ramelteon low dose doxepin zaleplon prescribing information 2026 OBSERVED | Google ↗ AI Mode ↗ | — | Other / navigational | — | — | 1x of 1 | |
FDA insomnia medication labels next morning impairment lemborexant daridorexant suvorexant ramelteon doxepin OBSERVED | Google ↗ AI Mode ↗ | — | Other / navigational | — | — | 1x of 1 |